Researchers has significantly improved the development of a new therapy for amyloid heart disease, leveraging Attruby. Early trial data indicates significant benefits for those affected by a debilitating illness. This emphasis represents BridgeBio's commitment to managing significant medical demands in the heart field. Attruby: BridgeBio's Novel A